Europe’s hemp industry hit a milestone last week when the European Union’s top court liberated CBD from the jurisdiction of an international drug treaty, declaring that hemp-derived cannabidiol is not a narcotic.
Please wait, loading...
The race for earliest submission of a Novel Food Dossier is a false one. This is especially the case when submissions made thus far, so we understand, lack the appropriate scientific data in respect of end products for which Authorisation is being contended and, in some cases, lack any scientific data in respect of the subject of the application at all.
On 14th May 2020 the Advocate General (Tanchev) of the Court of Justice of the European Union (CJEU) delivered their Opinion on the above question. The result is both a “Yes” and a “No”: National restrictions by Member States are possible, but such restrictions as are sought to be enforced must be (a) justified and (b) no more than necessary in order to achieve the justified aim.
Another snippet from the Global Cannabis Town Hall. Discussing collegiate Novel Food Applications and the potential issues with proprietary data. Answering questions on the future of the CBD Industry and the impact of Novel Foods post Covid-19. Watch the video here with Steve Oliver answering the question during the First Global Cannabinoid Webinar.